Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atsushi Takayanagi

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Biochemistry|January 3, 2007
Isolation and characterization of phage-displayed single chain antibodies recognizing nonreducing terminal mannose residues. 1. A new strategy for generation of anti-carbohydrate antibodiesKeiko Sakai, Yoshitaka Shimizu, Tomoki Chiba, et al.
Journal of Gastroenterology|September 7, 2005
Interleukin-17 augments tumor necrosis factor-alpha-induced granulocyte and granulocyte/macrophage colony-stimulating factor release from human colonic myofibroblastsAkira Andoh, Hirofumi Yasui, Osamu Inatomi, et al.
Plos One|June 20, 2020
Seasonal and annual fluctuations of deer populations estimated by a Bayesian state-space modelInoue Mizuki, Hiroki Itô, Michimasa Yamasaki, et al.
Biochemical and Biophysical Research Communications|May 18, 2005
Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cellsYutaka Machida, Tomoki Chiba, Atsushi Takayanagi, et al.
Tissue Engineering|June 15, 2006
Treatment of fulminant hepatic failure in rats using a bioartificial liver device containing porcine hepatocytes producing interleukin-1 receptor antagonistMasahiro Shinoda, Arno W Tilles, Go Wakabayashi, et al.
Plos One|July 23, 2015
Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for FcγRIIIa and Variable Antibody-Dependent Cellular Cytotoxicity ActivitiesMasaki Kurogochi, Masako Mori, Kenji Osumi, et al.
Hepatology (Baltimore, Md.)|July 31, 2008
Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in miceKengo Tomita, Yuichi Oike, Toshiaki Teratani, et al.
The Journal of Surgical Research|November 4, 2006
A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in ratsMasahiro Shinoda, Arno W Tilles, Naoya Kobayashi, et al.
The Journal of Surgical Research|October 4, 2011
Suppressive effects of interleukin-18 on liver function in rat liver allograftsShigeshi Ono, Hideaki Obara, Atsushi Takayanagi, et al.
The Journal of Surgical Research|December 16, 2014
Gene transfer of high-mobility group box 1 box-A domain in a rat acute liver failure modelMasayuki Tanaka, Masahiro Shinoda, Atsushi Takayanagi, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Biochemistry|January 3, 2007
Isolation and characterization of phage-displayed single chain antibodies recognizing nonreducing terminal mannose residues. 1. A new strategy for generation of anti-carbohydrate antibodiesKeiko Sakai, Yoshitaka Shimizu, Tomoki Chiba, et al.
Journal of Gastroenterology|September 7, 2005
Interleukin-17 augments tumor necrosis factor-alpha-induced granulocyte and granulocyte/macrophage colony-stimulating factor release from human colonic myofibroblastsAkira Andoh, Hirofumi Yasui, Osamu Inatomi, et al.
Plos One|June 20, 2020
Seasonal and annual fluctuations of deer populations estimated by a Bayesian state-space modelInoue Mizuki, Hiroki Itô, Michimasa Yamasaki, et al.
Biochemical and Biophysical Research Communications|May 18, 2005
Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cellsYutaka Machida, Tomoki Chiba, Atsushi Takayanagi, et al.
Tissue Engineering|June 15, 2006
Treatment of fulminant hepatic failure in rats using a bioartificial liver device containing porcine hepatocytes producing interleukin-1 receptor antagonistMasahiro Shinoda, Arno W Tilles, Go Wakabayashi, et al.
Plos One|July 23, 2015
Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for FcγRIIIa and Variable Antibody-Dependent Cellular Cytotoxicity ActivitiesMasaki Kurogochi, Masako Mori, Kenji Osumi, et al.
Hepatology (Baltimore, Md.)|July 31, 2008
Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in miceKengo Tomita, Yuichi Oike, Toshiaki Teratani, et al.
The Journal of Surgical Research|November 4, 2006
A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in ratsMasahiro Shinoda, Arno W Tilles, Naoya Kobayashi, et al.
The Journal of Surgical Research|October 4, 2011
Suppressive effects of interleukin-18 on liver function in rat liver allograftsShigeshi Ono, Hideaki Obara, Atsushi Takayanagi, et al.
The Journal of Surgical Research|December 16, 2014
Gene transfer of high-mobility group box 1 box-A domain in a rat acute liver failure modelMasayuki Tanaka, Masahiro Shinoda, Atsushi Takayanagi, et al.
Pageof 6